Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US6843961B2 · kind B2 · utility
18Cited by
44References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2003 |
| Grant date | Jan 18, 2005 |
| Priority date | — |
| Expiry date | Feb 3, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2202/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and apparatuses are provided for inactivation of pathogens in fluids containing blood products. Preferred methods include the steps of adding an effective, nontoxic amount of a photosensitizer such as riboflavin to the blood product and exposing the fluid to light having a peak wavelength.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.